Issued 2026-09-16 at $97.23 · now $97.23 (2026-09-16, +0.0% since)
Based on its own history, a month from the 2026-09-16 close, MET has typically landed between $87.83 and $108.23 — a range of −9.7% to +11.3% from the issuance price $97.23.
- Actual close
- Typical path (median)
- Middle 50% of outcomes
- 90% range
4,685 overlapping 1 month windows · 2008-01-02 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).
The cone is anchored at the 2026-09-16 issuance close ($97.23) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.
Where MET has typically landed a month from the 2026-09-16 close of $97.23 — the range is history, not a prediction.
- now $97.23 (+0.0%)
- typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $98.25 (+1.0%)
- middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $93.87–$102.62
- 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $87.83–$108.23
| Start | Return | Max drop | Max rise |
|---|---|---|---|
| 3 worst | |||
| 2009-02-05 | −59.4% | −60.6% | +1.8% |
| 2009-02-04 | −58.7% | −59.1% | +5.7% |
| 2009-02-03 | −57.6% | −57.6% | +9.6% |
| 3 best | |||
| 2009-03-05 | +109.3% | +0.0% | +111.2% |
| 2009-03-06 | +105.4% | +0.0% | +109.2% |
| 2008-11-20 | +99.4% | +0.0% | +126.9% |
4,685 overlapping windows · 2008-01-02 – 2026-09-16 · not cherry-picked
Fundamentals iCompany financials — revenue, earnings, margins — from the newest filings shown, each carried with its date.iAs-reported figures and standard ratios from FMP, as of 2026-07-25. Revenue, net income and free cash flow can toggle annual or quarterly; margin, ROE and debt-to-equity are shown by fiscal year. We report the figures and the trend — no target price and no over/under-valued call. More on /methodology.
Fair value — three views iIndependent reference estimates of worth (a cash-flow model, peer multiples, analyst targets), shown as separate views — not a single verdict.
iThree independent estimates of per-share value, each by a different method and each with its own assumptions: a discounted-cash-flow intrinsic value, a peer comparable (the median trailing P/E of 69 sector peers times this company's trailing EPS), and the analyst price-target consensus. They routinely disagree — that gap is the point. We show the three marks and the current price; we do not blend them into a single number or call the stock over- or under-valued. Marks as of the latest capture. More on /methodology.- DCF (intrinsic)$189.38
- Peer P/E × EPS · sector median 16.4× · n=69$84.53
- Analyst target · range $90.00–$105.00$96.00
- Current price · last close 2026-09-16$97.23
Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.
iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~19 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.Up-frequency and average month-over-month return · historical frequency, not a prediction
Reported insider & political trades
Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.
| Date | Person | Role | Action | Shares @ price | Value | Ownership Δ | vs S&P 1m | vs S&P 6m | Owned after | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-01 | DEBEL MARLENE | director | Sale | 21,312 @ $81.59 | $1.7M | −12.1% of holding | +8.0% | not yet — horizon still open | 154,380 | Form 4 · filed 2 days after the trade |
| 2025-05-12 | PAPPAS BILL | officer | Sale | 26,000 @ $80.49 | $2.1M | −28.0% of holding | −5.3% | −20.4% | 66,744 | Form 4 · filed 1 day after the trade |
| 2024-12-13 | DEBEL MARLENE | director | Sale | 22,810 @ $82.88 | $1.9M | −17.4% of holding | +5.2% | −3.6% | 108,507 | Form 4 · filed 4 days after the trade |
| 2024-12-13 | Khalaf Michel | director | Sale | 20,926 @ $82.84 | $1.7M | −4.0% of holding | +5.2% | −3.6% | 500,799 | Form 4 · filed 4 days after the trade |
The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.
241 award / exercise / gift records — not counted as purchases
Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.
| Date | Person | Role | Action | Shares | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-08 | HUBBARD ROBERT GLENN | director | Award / grant | 618 | 108,191 | Form 4 |
| 2026-09-08 | Kennard William E | director | Award / grant | 294 | 47,704 | Form 4 |
| 2026-09-08 | MCKENZIE DIANA | director | Award / grant | 157 | 25,385 | Form 4 |
| 2026-09-08 | TADROS RAMY | officer | Award / grant | 115 | 212,695 | Form 4 |
| 2026-09-08 | Johnson Jeh C. | director | Award / grant | 59 | 9,557 | Form 4 |
| 2026-09-08 | Harris Carla A | director | Award / grant | 42 | 11,157 | Form 4 |
| 2026-09-08 | Hay Laura J | director | Award / grant | 39 | 6,357 | Form 4 |
| 2026-09-08 | Mumenthaler Christian Stephane | director | Award / grant | 21 | 3,474 | Form 4 |
| 2026-09-08 | Glaser Daniel S | director | Award / grant | 10 | 2,705 | Form 4 |
| 2026-08-31 | McCallion John D. | officer | Withheld for tax | 6,057 | 269,137 | Form 4 |
| 2026-08-31 | TADROS RAMY | officer | Withheld for tax | 4,366 | 212,580 | Form 4 |
| 2026-08-31 | DEBEL MARLENE | director | Withheld for tax | 4,030 | 150,350 | Form 4 |
| 2026-08-31 | PAPPAS BILL | officer | Withheld for tax | 4,030 | 79,716 | Form 4 |
| 2026-06-16 | HUBBARD ROBERT GLENN | director | Award / grant | 1,016 | 107,573 | Form 4 |
| 2026-06-16 | Kennard William E | director | Award / grant | 587 | 47,410 | Form 4 |
| 2026-06-16 | Johnson Jeh C. | director | Award / grant | 587 | 9,498 | Form 4 |
| 2026-06-16 | MCKENZIE DIANA | director | Award / grant | 587 | 25,229 | Form 4 |
| 2026-06-16 | Mumenthaler Christian Stephane | director | Award / grant | 587 | 3,452 | Form 4 |
| 2026-06-16 | Glaser Daniel S | director | Award / grant | 587 | 2,695 | Form 4 |
| 2026-06-16 | Hay Laura J | director | Award / grant | 587 | 6,318 | Form 4 |
| 2026-06-16 | Harris Carla A | director | Award / grant | 587 | 11,115 | Form 4 |
| 2026-06-16 | Seitz Michelle | director | Award / grant | 587 | 1,581 | Form 4 |
| 2026-06-16 | WEINBERGER MARK A | director | Award / grant | 587 | 19,388 | Form 4 |
| 2026-06-09 | HUBBARD ROBERT GLENN | director | Award / grant | 678 | 106,557 | Form 4 |
| 2026-06-09 | Kennard William E | director | Award / grant | 322 | 46,823 | Form 4 |
| 2026-06-09 | MCKENZIE DIANA | director | Award / grant | 169 | 24,642 | Form 4 |
| 2026-06-09 | TADROS RAMY | officer | Award / grant | 127 | 216,946 | Form 4 |
| 2026-06-09 | Johnson Jeh C. | director | Award / grant | 61 | 8,911 | Form 4 |
| 2026-06-09 | Harris Carla A | director | Award / grant | 42 | 10,528 | Form 4 |
| 2026-06-09 | Hay Laura J | director | Award / grant | 39 | 5,731 | Form 4 |
| 2026-06-09 | Mumenthaler Christian Stephane | director | Award / grant | 20 | 2,865 | Form 4 |
| 2026-06-09 | Glaser Daniel S | director | Award / grant | 7 | 2,108 | Form 4 |
| 2026-06-01 | DEBEL MARLENE | director | Option exercise | 10,600 | 164,980 | Form 4 |
| 2026-06-01 | DEBEL MARLENE | director | Option exercise | 10,712 | 175,692 | Form 4 |
| 2026-06-01 | DEBEL MARLENE | director | Option exercise | 10,712 | 0 | Form 4 |
| 2026-06-01 | DEBEL MARLENE | director | Option exercise | 10,600 | 0 | Form 4 |
| 2026-04-30 | O'Neill Adrienne Karen | officer | Award / grant | 12,485 | 27,042 | Form 4 |
| 2026-04-30 | O'Neill Adrienne Karen | officer | Award / grant | 12,485 | 27,042 | Form 4 |
| 2026-04-01 | HUBBARD ROBERT GLENN | director | Award / grant | 1,248 | 105,878 | Form 4 |
| 2026-04-01 | Glaser Daniel S | director | Award / grant | 721 | 2,101 | Form 4 |
Source: SEC Form 4 filings. Each row links to its original filing.
Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.
Congressional disclosures iStock trades disclosed by members of Congress for this company, by the date they were filed.iDisclosures shown as facts. A purchase “cluster” (≥2 members of Congress filing a buy within 90 days) has historically preceded modestly higher forward returns — and it persisted out-of-sample, though it roughly halved after 2021 (see below). A descriptive historical tendency, not a signal to trade and not used in our forecast. See /methodology.
As of 2026-09-16 · point-in-time by filed date
A cluster = ≥2 members of Congress filing a purchase within 90 days. The historical tilt persisted after 2021 but roughly halved (+45 → +32 bp/mo forward 1-month vs the S&P 500 weekly-grid baseline). Descriptive historical tendency — not a signal to trade, and not used in our forecast (audition-log 2026-07-27, recomputed 2026-09-08).
| Member | Chamber | Type | Filed | Traded | Size |
|---|---|---|---|---|---|
| Alan Armstrong | Senate | purchase | 2026-07-21 | 2026-03-27 | $1–15K |
| Ro Khanna | House | purchase | 2026-07-06 | 2026-06-02 | $1–15K |
| Ro Khanna | House | purchase | 2026-05-11 | 2026-04-24 | $1–15K |
| Ro Khanna | House | purchase | 2026-04-07 | 2026-03-10 | $1–15K |
| Ro Khanna | House | sale | 2026-04-07 | 2026-03-23 | $1–15K |
| Ro Khanna | House | sale | 2026-04-07 | 2026-03-30 | $1–15K |
| Ro Khanna | House | purchase | 2026-03-09 | 2026-02-24 | $1–15K |
| Ro Khanna | House | purchase | 2026-03-09 | 2026-02-24 | $1–15K |
| Ro Khanna | House | sale | 2026-02-06 | 2026-01-22 | $1–15K |
| Ro Khanna | House | sale | 2026-02-06 | 2026-01-29 | $15–50K |
| Ro Khanna | House | sale | 2025-12-08 | 2025-11-03 | $1–15K |
| Ro Khanna | House | purchase | 2025-12-08 | 2025-11-06 | $1–15K |
| Ro Khanna | House | purchase | 2025-12-08 | 2025-11-10 | $1–15K |
| Ro Khanna | House | purchase | 2025-12-08 | 2025-11-14 | $1–15K |
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.